The price-to-earnings ratio for Prestige Consumer Healthcare Inc (NYSE: PBH) is 19.52x, which is above its average ratio. Moreover, the 36-month beta value for PBH is 0.46. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for PBH is 48.77M and currently, short sellers hold a 3.76% of that float. On June 19, 2025, PBH’s average trading volume was 361.92K shares.
PBH) stock’s latest price update
The stock of Prestige Consumer Healthcare Inc (NYSE: PBH) has decreased by -0.05 when compared to last closing price of 83.68. Despite this, the company has experienced a -1.74% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-17 that TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) — Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contaminated food. The second type can cause stomach cramps and diarrhea that can start 8 to 16 hours after eating or drinking contaminated food. Diarrhea may be a small volume or profuse and watery. Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.
PBH’s Market Performance
PBH’s stock has fallen by -1.74% in the past week, with a monthly drop of -5.96% and a quarterly rise of 0.01%. The volatility ratio for the week is 0.65% while the volatility levels for the last 30 days are 1.18% for Prestige Consumer Healthcare Inc The simple moving average for the last 20 days is -1.48% for PBH stock, with a simple moving average of 4.33% for the last 200 days.
Analysts’ Opinion of PBH
Many brokerage firms have already submitted their reports for PBH stocks, with Sidoti repeating the rating for PBH by listing it as a “Neutral.” The predicted price for PBH in the upcoming period, according to Sidoti is $90 based on the research report published on December 09, 2024 of the previous year 2024.
DA Davidson, on the other hand, stated in their research note that they expect to see PBH reach a price target of $93, previously predicting the price at $65. The rating they have provided for PBH stocks is “Buy” according to the report published on June 21st, 2024.
Canaccord Genuity gave a rating of “Buy” to PBH, setting the target price at $71 in the report published on November 17th of the previous year.
PBH Trading at -0.17% from the 50-Day Moving Average
After a stumble in the market that brought PBH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.11% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PBH starting from Fritz Mary Beth, who sale 1,678 shares at the price of $90.00 back on Mar 10 ’25. After this action, Fritz Mary Beth now owns 17,157 shares of Prestige Consumer Healthcare Inc, valued at $151,020 using the latest closing price.
Fritz Mary Beth, the Officer of Prestige Consumer Healthcare Inc, proposed sale 1,678 shares at $90.00 during a trade that took place back on Mar 10 ’25, which means that Fritz Mary Beth is holding shares at $151,020 based on the most recent closing price.
Stock Fundamentals for PBH
Current profitability levels for the company are sitting at:
- 0.3 for the present operating margin
- 0.56 for the gross margin
The net margin for Prestige Consumer Healthcare Inc stands at 0.19. The total capital return value is set at 0.1. Equity return is now at value 12.30, with 6.30 for asset returns.
Based on Prestige Consumer Healthcare Inc (PBH), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 4.85. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 7.07.
Currently, EBITDA for the company is 353.11 million with net debt to EBITDA at -0.13. When we switch over and look at the enterprise to sales, we see a ratio of 3.59. The receivables turnover for the company is 5.86for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.20.
Conclusion
To wrap up, the performance of Prestige Consumer Healthcare Inc (PBH) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
